Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study.
García de Lucas MD, Caballero I, Fernández-García JC, Domínguez-Rodríguez M, Moreno-Moreno P, Jiménez-Millán A, Botana-López M, Avilés B, Merino-Torres JF, Soto A, Tejera C, Morales C.
García de Lucas MD, et al. Among authors: caballero i.
Front Endocrinol (Lausanne). 2023 Oct 24;14:1240279. doi: 10.3389/fendo.2023.1240279. eCollection 2023.
Front Endocrinol (Lausanne). 2023.
PMID: 37955013
Free PMC article.